US Pharmaceutical Sterility Testing Market

ID: MRFR/Pharma/18148-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Pharmaceutical Sterility Testing Market Research Report: Size, Share, Trend Analysis By Applications (Sterile Drugs, Medical Devices, Biologics), By Product Type (Instruments, Kits & Reagents, Services), By Types (In-house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing) and By End Users (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035
US Pharmaceutical Sterility Testing Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.3%
2024 Market Size$ 141.54 Million
2025 Market Size$ 149.04 Million
2035 Market Size$ 249.85 Million
Key Players
Merck KGaA
Thermo Fisher Scientific Inc.
Charles River Laboratories International Inc.
Becton Dickinson and Company
Eppendorf AG
BioMerieux SA
Trends
  • Regulatory Compliance and Safety Standards
  • Automation and Technological Advancements
  • Rising Demand for Biologics and Sterile Products
Opportunities
  • Increasing Regulatory Scrutiny
  • Expansion of Biopharmaceuticals
  • Rising Consumer Health Awareness
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Industrial Automation & Equipment, BY Sample (USD Million)
      1. 4.1.1 Sterile Drugs
      2. 4.1.2 Medical Devices
      3. 4.1.3 Biologics
    2. 4.2 Industrial Automation & Equipment, BY Product Type (USD Million)
      1. 4.2.1 Instruments
      2. 4.2.2 Kits & Reagents
      3. 4.2.3 Services
    3. 4.3 Industrial Automation & Equipment, BY Type (USD Million)
      1. 4.3.1 In-house
      2. 4.3.2 Outsourcing
    4. 4.4 Industrial Automation & Equipment, BY Test Type (USD Million)
      1. 4.4.1 Sterility Testing
      2. 4.4.2 Bioburden Testing
      3. 4.4.3 Bacterial Endotoxin Testing
    5. 4.5 Industrial Automation & Equipment, BY End User (USD Million)
      1. 4.5.1 Compounding Pharmacies
      2. 4.5.2 Medical Devices Companies
      3. 4.5.3 Pharmaceutical Companies
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Merck KGaA (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Thermo Fisher Scientific Inc. (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Charles River Laboratories International Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Becton Dickinson and Company (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Eppendorf AG (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 BioMerieux SA (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 MilliporeSigma (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sartorius AG (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY SAMPLE
    3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 US MARKET ANALYSIS BY TYPE
    5. 6.5 US MARKET ANALYSIS BY TEST TYPE
    6. 6.6 US MARKET ANALYSIS BY END USER
    7. 6.7 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
    10. 6.10 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    12. 6.12 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
    13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SAMPLE, 2024 (% SHARE)
    14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SAMPLE, 2024 TO 2035 (USD Million)
    15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PRODUCT TYPE, 2024 (% SHARE)
    16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
    18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
    19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TEST TYPE, 2024 (% SHARE)
    20. 6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TEST TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 (% SHARE)
    22. 6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SAMPLE, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY TEST TYPE, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Pharmaceutical Sterility Testing Market Segmentation

US Pharmaceutical Sterility Testing Market By Sample (USD Million, 2025-2035)

  • Sterile Drugs
  • Medical Devices
  • Biologics

US Pharmaceutical Sterility Testing Market By Product Type (USD Million, 2025-2035)

  • Instruments
  • Kits & Reagents
  • Services

US Pharmaceutical Sterility Testing Market By Type (USD Million, 2025-2035)

  • In-house
  • Outsourcing

US Pharmaceutical Sterility Testing Market By Test Type (USD Million, 2025-2035)

  • Sterility Testing
  • Bioburden Testing
  • Bacterial Endotoxin Testing

US Pharmaceutical Sterility Testing Market By End User (USD Million, 2025-2035)

  • Compounding Pharmacies
  • Medical Devices Companies
  • US Pharmaceutical Sterility Testing Market Companies

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.